RET-driven cancers
Eli Lilly Sets Example for Roche with Positive Retevmo Results in Thyroid Cancer, Highlighting Feasibility of Trial
Anika Sharma
Just a few weeks ago, Roche had expressed doubts about the feasibility of a Phase 3 study involving its RET ...
